Senseonics Holdings

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Applied Genetic Technologies

Atossa Genetics

Clover Health Investments

Citius Pharmaceuticals

InvestorPlace is closing out a busy week of trading with a look at the Reddit penny stocks seeing the most chatter on Friday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared first on InvestorPlace.

5 Reddit Penny Stocks Seeing the Most Chatter Friday

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q1 2021 Results - Earnings Call Transcript

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2021. Recent Highlights & Accomplishments: Generated first quarter 2021 revenue of $2.85 million primarily driven by sales in the E.U. FDA review resumed in mid-April with t

Senseonics Holdings, Inc. Reports First Quarter 2021 Financial Results

SENS stock is worth following in the growth sector of diabetes management devices and has growth ahead almost certainly. The post Senseonics Holdings Has a Legitimate Chance in a Burgeoning Market appeared first on InvestorPlace.

Senseonics Holdings Has a Legitimate Chance in a Burgeoning Market

Take advantage of the drift in Senseonics before it recovers with a nod by the FDA nod. SENS stock will skyrocket after FDA approval.

Advantage the Drift in Senseonics Stock Before It Recovers on FDA Nod

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Senseonics Holdings (SENS) Report Negative Earnings Next Week? What You Should Know

As far as speculative picks go, SENS stock is an intriguing option for investors looking for a speculative small cap play right now. The post Why Senseonics Is An Intriguing Speculative Buy At These Levels appeared first on InvestorPlace.

Why Senseonics Is An Intriguing Speculative Buy At These Levels

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, May 13, 2021. Management will hold a conference call to review the company's first quarter 2021 performance starting at 4:30 p.m

Senseonics Holdings, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 13, 2021 at 4:30 p.m. Eastern Time

Koss

Luminar Technologies

SNDL Inc.

Electrameccanica

ZK International Group

Zomedica

While cheap stocks have captured the imagination of speculators everywhere, you should avoid this space until it stabilizes. The post 7 Cheap Stocks to Avoid Until the Hype Retreats appeared first on InvestorPlace.

7 Cheap Stocks to Avoid Until the Hype Retreats

Transocean

Uxin Ltd - ADR

Looking for penny stocks to watch before May? Check these 3 out The post Hot Penny Stocks to Buy Today?

Hot Penny Stocks to Buy Today? 3 to Watch Before May 2021

You might never have considered investing in a glucose monitoring company, but SENS stock is a good name to consider for health-care investors. The post Senseonics Holdings Is a Worthy Niche Diabetes-Care Investment appeared first on InvestorPlace.

Senseonics Holdings Is a Worthy Niche Diabetes-Care Investment

Up over 250% in less than a year, what's behind the rise of this hot stock?

Can This Popular Reddit Stock Make You Rich?

Senseonics develops glucose monitoring products. Thanks to Reddit, SENS stock is up 111% year-to-date.

Mulling Senseonics Holdings? Beware What Lurks On Its Balance Sheet

Avinger

GT Biopharma Inc

List Of Penny Stocks To Watch Right Now The post Hot Penny Stocks To Watch In April 2021 If Biotech Is A Focus appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks To Watch In April 2021 If Biotech Is A Focus

Senseonics will likely rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next five years once it receives FDA approval.

Senseonics Stock Will Likely Rise on the Same Trajectory As DexCom

SENS stock is banking on an FDA approval for its diabetes sensor. However, you'll want to analyze the fundamentals before proceeding.

Analyze Senseonics Thoroughly Before You Feed the Meme

Is SENS stock really just another "meme stock"? After examining Senseonics' tech innovations, it's clear that this is a serious investment.

Own a Few Shares of Senseonics Holdings to Wager on Life-Changing Technology

Senseonics shares have suddenly plunged on no news from recent highs giving investors a good opportunity to buy into one of the most compelling growth stories in the market. The company aims to disrupt the CGM market in partnership with Ascensia Diabetes Care, one of the top diabetes companies in the world.

Senseonics: A Potential Multi-Bagger From Here

The stock price of Senseonics Holdings Inc (NYSEAMERICAN: SENS) fell by over 5% pre-market. This is why it happened.

SENS Stock Price Fell Over 5% Pre-Market: Why It Happened

Senseonics Holdings, Inc.'s (SENS) CEO Tim Goodnow on Q4 2020 Results - Earnings Call Transcript

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended December 31, 2020. Recent Highlights & Accomplishments: Generated fourth quarter 2020 revenue of $3.9 million primarily driven by orders to support the European installe

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming virtual H.C. Wainwright Global Life Sciences Conference. Management is scheduled to participate and hold one-on-one meetings Tuesday, March 9, 2021. A presentation webcast will be available

Senseonics to Participate in the H.C. Wainwright Global Life Sciences Conference

The stock price of Senseonics Holdings Inc (NYSEAMERICAN: SENS) is trading up over 8%. This is why it happened.

SENS Stock Price Increases Over 8% Pre-Market: Why It Happened

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, March 4, 2021. Management will hold a conference call to review the company's fourth quarter and full year 2020 p

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for March 4, 2021 at 4:30 p.m. Eastern Time

The stock price of Senseonics Holdings Inc (NYSEAMERICAN: SENS) increased by 26.92% today. This is why it happened.

News for Senseonics Holdings Stock (SENS)